A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity.

Correlations between enrichment scores in replicate drug treatments were highly significant (p<10 −900 ; n ≈ 10 6 ) although of modest magnitude (0.1 to 0.3) ( Figure 4B ).

also in 132,142 other papers